Doty, Daniel T.
Roy, Mahua
Kukutla, Phanidhar
Lucarelli, Nicholas
Struss, Peter E.
King, Lindsay E.
Chabot, Jeffrey R.
Narula, Jatin
Neubert, Hendrik
Goihberg, Polina https://orcid.org/0000-0002-6275-8437
Article History
Received: 22 November 2024
Accepted: 11 March 2025
First Online: 7 April 2025
Change Date: 14 April 2025
Change Type: Update
Change Details: The Supplementary Material file 3 (Supplementary Figures captions) was not included in the original publication, this article has been updated.
Declarations
:
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: All authors were employees of Pfizer Inc. when they contributed to this study and might hold equity in the company. J.N, L.E.K., J.R.C., H.N. and P.G. are current employees of Pfizer Inc. M.R. is presently employed by AstraZeneca PLC; P.S. is currently employed by BioLegend. P.K. is currently employed by Thinkhat Venture Studious Inc. D.T.D. and N.L. declare no other conflict of interest.
: This work was financially supported by Pfizer Inc.
: Not applicable.